Triple-negative breast cancer (TNBC) is an aggressive type of heterogenous breast cancer that tests negative for the expression of estrogen, progesterone, and human epidermal growth factor 2 receptors (HER2). This evidence concerns the gene ERBB2 and breast cancer.